[Anti-GBM disease].
Yamada
Akira
A
First Department of Internal Medicine, Kyorin University School of Medicine.
D019867:Anti-Glomerular Basement Membrane Disease / Q000175:diagnosis / Q000276:immunology / Q000503:physiopathology / Q000628:therapy; D000906:Antibodies / Q000032:analysis / Q000276:immunology; D001323:Autoantibodies; D001324:Autoantigens / Q000276:immunology; D015415:Biomarkers / Q000032:analysis; D024141:Collagen Type IV / Q000276:immunology; D003520:Cyclophosphamide / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007668:Kidney / Q000473:pathology; D010956:Plasmapheresis; D011239:Prednisolone / Q000627:therapeutic use; D006435:Renal Dialysis
D000906:Antibodies; D001323:Autoantibodies; D001324:Autoantigens; D015415:Biomarkers; D024141:Collagen Type IV; D007166:Immunosuppressive Agents; C051951:antiglomerular basement membrane antibody; C057112:type IV collagen alpha3 chain; D003520:Cyclophosphamide; D011239:Prednisolone